Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
Frontiers in Immunology|February 9, 2026
Anti-angiogenic therapies in cancer: from endogenous inhibitors to bispecific VEGF x PD-(L)1 antibodiesLuis Álvarez-Vallina, Laura SanzTrends in Molecular Medicine|June 28, 2003
The extracellular matrix: a new turn-of-the-screw for anti-angiogenic strategiesLaura Sanz, Luis Alvarez-VallinaExpert Opinion on Biological Therapy|November 18, 2010
The therapeutic potential of engineered human neovessels for cell-based gene therapyLuís Alvarez-Vallina, Laura SanzAntibodies (Basel, Switzerland)|October 26, 2021
Engineered mRNA and the Rise of Next-Generation AntibodiesLaura Sanz, Luis Álvarez-VallinaExpert Opinion on Therapeutic Targets|November 23, 2005
Antibody-based antiangiogenic cancer therapyLaura Sanz, Luis Alvarez-VallinaPlos One|June 27, 2013
Multilamellar structures and filament bundles are found on the cell surface during bunyavirus egressLaura Sanz-Sánchez, Cristina RiscoLeukemia|January 5, 2024
Harnessing upregulated E-selectin while enhancing SDF-1α sensing redirects infused NK cells to the AML-perturbed bone marrowLaura Sanz-Ortega, Agneta Andersson, Mattias CarlstenTrends in Immunology|April 23, 2004
Antibodies and gene therapy: teaching old 'magic bullets' new tricksLaura Sanz, Belén Blanco, Luis Alvarez-VallinaInternational Review of Cell and Molecular Biology|July 1, 2022
Applications of trimerbodies in cancer immunotherapyMarta Compte, Laura Sanz, Luis Álvarez-VallinaCurrent Opinion in Biotechnology|March 26, 2011
Engineering human cells for in vivo secretion of antibody and non-antibody therapeutic proteinsDavid Sánchez-Martín, Laura Sanz, Luis Álvarez-VallinaPageof 11